Suppr超能文献

苯磺酸瑞马唑仑用于 ICU 行有创机械通气术后患者镇静的前瞻性剂量反应研究。

Remimazolam besylate for the sedation of postoperative patients undergoing invasive mechanical ventilation in the ICU: a prospective dose‒response study.

机构信息

Department of Critical Care Medicine, Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, 430022, China.

Institute of Anesthesia and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

出版信息

Sci Rep. 2022 Nov 8;12(1):19022. doi: 10.1038/s41598-022-20946-6.

Abstract

This single-center study aimed to determine the effective dose and safety of remimazolam besylate for the sedation of postoperative patients undergoing invasive mechanical ventilation in the intensive care unit (ICU). Mechanically ventilated patients admitted to the ICU after surgery were included. The Narcotrend index (NTI) was used to assess the depth of sedation, and the Richmond Agitation-Sedation Scale (RASS) score was also recorded. Remimazolam besylate was administered initially at a loading dose of 0.02 mg/kg, followed by a gradual increase of 0.005 mg/kg each time until the targeted depth of sedation was achieved (NTI 65-94). A maintenance dose of remimazolam besylate was administered starting at 0.2 mg/kg/h, followed by increments or subtractions of 0.05 mg/kg/h each time until a satisfactory depth of sedation was achieved and maintained for at least 30 min. The demographic data, anesthesia, surgery types, hemodynamics and respiratory parameters were recorded. Adverse events and adverse drug reactions were monitored for safety. Twenty-three patients were eventually included in this study covering a period of 1 year. A satisfactory depth of sedation was achieved by a single intravenous infusion of remimazolam besylate at a loading dose of 0.02-0.05 mg/kg followed by a maintenance dose of 0.20-0.35 mg/kg/h. There were no significant changes in hemodynamic and respiratory parameters within 10 min after the administration of remimazolam besylate. In addition, a significant correlation was observed between the NTI and the RASS score for assessing sedation (r = 0.721, P < 0.001). The NTI showed a predictive probability for a RASS score of 0.817. Remimazolam besylate was effective for mild/moderate sedation of invasively mechanically ventilated postoperative patients in the ICU while maintaining excellent respiratory and hemodynamic stability. The NTI can be used as a good tool for the objective evaluation of the depth of sedation and agitation.

摘要

这项单中心研究旨在确定甲磺酸雷米唑仑用于 ICU 中接受有创机械通气的术后患者镇静的有效剂量和安全性。纳入手术后入住 ICU 的机械通气患者。使用麻醉深度指数(NTI)评估镇静深度,同时记录 Richmond 躁动-镇静评分(RASS)。雷米唑仑的初始负荷剂量为 0.02mg/kg,然后每次递增 0.005mg/kg,直至达到目标镇静深度(NTI 65-94)。维持剂量为 0.2mg/kg/h,然后每次增减 0.05mg/kg/h,直至达到满意的镇静深度并维持至少 30 分钟。记录患者的人口统计学数据、麻醉、手术类型、血流动力学和呼吸参数。监测不良反应和药物不良反应以确保安全性。最终这项研究共纳入 23 例患者,研究时间为 1 年。通过单次静脉输注雷米唑仑负荷剂量 0.02-0.05mg/kg,然后维持剂量 0.20-0.35mg/kg/h,即可达到满意的镇静深度。雷米唑仑给药后 10 分钟内,血流动力学和呼吸参数无显著变化。此外,NTI 与 RASS 评分评估镇静深度之间存在显著相关性(r=0.721,P<0.001)。NTI 对 RASS 评分为 0 的预测概率为 0.817。甲磺酸雷米唑仑可有效用于 ICU 中接受有创机械通气的术后患者的轻度/中度镇静,同时保持良好的呼吸和血液动力学稳定性。NTI 可作为评估镇静和躁动深度的客观工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b0f/9643476/92992a672cae/41598_2022_20946_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验